Q: Any idea why TH has been so weak lately. I know sales have been short of expectations for their new life saving drug but they are still rising slowly. Also their older drug Egrifta may have some benefits for people with NAFLD/NASH. Balance sheet is good.
Should one buy here?
Should one buy here?